Status:
COMPLETED
DEB vs Thin-DES in DES-ISR: Long Term Outcomes (DEB Dragon Registry)
Lead Sponsor:
Medical University of Silesia
Collaborating Sponsors:
Wojciech Wojakowski
Conditions:
In Stent Restenosis
Brief Summary
Data regarding the usefulness of percutaneous coronary intervention (PCI) with drug eluting balloon (DEB) vs. thin struts drug eluting stents (thin-DES) for treating in-stent restenosis (ISR) in every...
Eligibility Criteria
Inclusion
- • All consecutive patients with DES-ISR who were treated with either paclitaxel-DEB or thin-DES.
Exclusion
- PCI with DES struts thickness \>100μm
- PCI with DEB and thin-DES in the same procedure
- PCI of other vascular territories during the same procedure
- PCI in saphenous vain graft or internal mammary artery
Key Trial Info
Start Date :
October 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
1369 Patients enrolled
Trial Details
Trial ID
NCT04415216
Start Date
October 10 2019
End Date
March 1 2020
Last Update
September 21 2021
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Invasive Cardiology, Medical University of Bialystok
Bialystok, Poland, 15-089
2
Cardiovascular Institute, Nicolaus Copernicus University, Bydgoszcz, Poland
Bydgoszcz, Poland
3
First Department of Cardiology, Medical University of Gdansk, Gdansk, Poland
Gdansk, Poland
4
Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland
Katowice, Poland, 40-635